arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

RadNet, Inc.

RDNT Health Care Medical Specialities
$73.71
Today
as of Sep 4, 16:53 ET
Last 30 days +19.83% Jul 27 → Sep 04
$60.25 $64.83 $69.41 $73.99 $78.57 Jul 27 Aug 04 Aug 12 Aug 19 Aug 27 Sep 04
Open
$73.82
High
$74.70
Low
$73.36
Volume
$501,982
Avg Vol
$812,671
Mkt Cap
$6.1B
P/E (TTM)
—
Beta
—
52w High
$85.84
52w Low
$50.82
Div Yield
—
Shares Out
$79M

Recent Press Releases & News last 60 days · 15 items

Sep 4 · 09:58 Insider Monkey
RadNet (RDNT) Posts Record Revenue But Profit Growth Lags
Aug 11 · 15:20 Zacks
RDNT Q2 Earnings & Sales Beat on Advanced Imaging, Guidance Raised
Aug 11 · 12:24 MT Newswires
B. Riley Adjusts Price Target on RadNet to $96 From $83, Maintains Buy Rating
▸ Show all 15 press releases & news Free account →

Overview

52-week range
$51
$86
65% of range
Avg surprise (last 3)
-41.2%
Avg reaction (last 2)
-0.8%
50% positive
Latest IV / EM
36%
EM ±5.6% · $75 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.36$-0.19$-0.03$0.14$0.31 Actual $-0.36Actual $0.12Actual $0.25Actual $-0.04Actual $-0.04Actual $0.04Actual $-0.35Est $-0.17Actual $0.31Est $0.17Actual $0.07Actual $-0.28Est $-0.14Actual $0.10 MarJunSepMarJunSepMar/2025Jun/2025SepMar/2026Jun
Revenue vs Net Income Revenue Net income
$-38M$135M$308M$481M$654M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $0.10 — — — — financials
Sun May 10, 2026Mar/2026 $-0.28 $-0.14 -100.0% +20.0% -3.9% earnings
Tue Sep 30, 2025Sep 2025 $0.07 — — — — financials
Sun Aug 10, 2025Jun/2025 $0.31 $0.17 +82.3% — — earnings
Sun May 11, 2025Mar/2025 $-0.35 $-0.17 -105.9% — +2.3% earnings
Mon Sep 30, 2024Sep 2024 $0.04 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.04 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.04 — — — — financials
Sat Sep 30, 2023Sep 2023 $0.25 — — — — financials
Fri Jun 30, 2023Jun 2023 $0.12 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.36 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$623M$576M—$523M$498M$471M—$461M
Cost of revenue————————
Gross profit————————
Operating income$39M$-24M—$27M$31M$-24M—$34M
Net income$8M$-33M—$5M$14M$-38M—$3M
EPS (diluted)$0.10$-0.43—$0.07$0.19$-0.51—$0.04

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$726M$455M$767M$805M$833M$717M$740M$749M
Inventory————————
Total current assets$1.04B$741M$1.03B$1.08B$1.09B$1.02B$1.02B$1.02B
Total assets$4.23B$3.89B$3.76B$3.67B$3.51B$3.34B$3.29B$3.28B
Long-term debt$1.30B$1.06B$1.06B$1.07B$1.08B$985M$992M$996M
Total liabilities$2.83B$2.53B$2.40B$2.35B$2.34B$2.20B$2.15B$2.16B
Total equity$1.10B$1.35B$1.09B$1.06B$1.18B$1.14B$902M$1.12B

Implied volatility — last 90 days

35%79%122%166%210% Jun 07 — IV 52% · EM ±7.3%Jun 08 — IV 53% · EM ±7.0%Jun 09 — IV 61% · EM ±7.7%Jun 10 — IV 55% · EM ±6.4%Jun 11 — IV 52% · EM ±5.7%Jun 12 — IV 54% · EM ±5.6%Jun 15 — IV 73% · EM ±5.3%Jun 16 — IV 67% · EM ±4.0%Jun 17 — IV 211% · EM ±8.8%Jun 19 — IV 51% · EM ±11.2%Jun 22 — IV 51% · EM ±10.6%Jun 23 — IV 52% · EM ±10.6%Jun 24 — IV 54% · EM ±10.9%Jun 25 — IV 52% · EM ±10.2%Jun 26 — IV 47% · EM ±9.1%Jun 29 — IV 47% · EM ±8.3%Jun 30 — IV 50% · EM ±8.6%Jul 01 — IV 41% · EM ±6.9%Jul 02 — IV 42% · EM ±6.8%Jul 03 — IV 44% · EM ±6.8%Jul 06 — IV 48% · EM ±6.6%Jul 07 — IV 59% · EM ±7.8%Jul 08 — IV 43% · EM ±5.4%Jul 09 — IV 49% · EM ±5.8%Jul 10 — IV 46% · EM ±5.1%Jul 13 — IV 59% · EM ±4.9%Jul 14 — IV 78% · EM ±5.7%Jul 15 — IV 63% · EM ±3.7%Jul 16 — IV 154% · EM ±6.4%Jul 20 — IV 61% · EM ±14.3%Jul 21 — IV 56% · EM ±13.0%Jul 22 — IV 61% · EM ±13.8%Jul 23 — IV 62% · EM ±13.9%Jul 24 — IV 66% · EM ±14.5%Jul 27 — IV 62% · EM ±13.0%Jul 28 — IV 73% · EM ±14.9%Jul 29 — IV 70% · EM ±13.9%Jul 30 — IV 72% · EM ±14.2%Jul 31 — IV 70% · EM ±13.4%Aug 03 — IV 70% · EM ±12.3%Aug 04 — IV 76% · EM ±13.0%Aug 05 — IV 75% · EM ±12.5%Aug 06 — IV 84% · EM ±13.6%Aug 07 — IV 78% · EM ±12.2%Aug 10 — IV 41% · EM ±5.7%Aug 11 — IV 36% · EM ±4.7%Aug 12 — IV 44% · EM ±5.5%Aug 13 — IV 40% · EM ±4.8%Aug 14 — IV 49% · EM ±5.4%Aug 17 — IV 48% · EM ±4.0%Aug 18 — IV 59% · EM ±4.3%Aug 19 — IV 80% · EM ±4.7%Aug 20 — IV 109% · EM ±4.5%Aug 24 — IV 40% · EM ±8.3%Aug 25 — IV 41% · EM ±8.5%Aug 26 — IV 39% · EM ±7.8%Aug 27 — IV 35% · EM ±6.9%Aug 28 — IV 35% · EM ±6.7%Aug 31 — IV 37% · EM ±6.5%Sep 01 — IV 38% · EM ±6.5%Sep 02 — IV 37% · EM ±6.2%Sep 03 — IV 39% · EM ±6.3%Sep 04 — IV 36% · EM ±5.6%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in